National Cancer Institute Amended Notice of Meeting

---
identifier: "/us/fr/2018-00872"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2018-00872"
section_name: "National Cancer Institute Amended Notice of Meeting"
positive_law: false
currency: "2018-01-19"
last_updated: "2018-01-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "2018-00872"
document_type: "notice"
publication_date: "2018-01-19"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  National Cancer Institute Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, February 08, 2018, 09:00 a.m. to February 08, 2018, 04:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was published in the *Federal Register* on December 27, 2017, 82 FR 61309.

This meeting notice is amended to change the meeting title from “Cancer Cachexia Therapy and Local Delivery of Chemopreventive Agents” to “TEP-9A: Local Delivery of Chemopreventive  Agents for Cancer”. The meeting is closed to the public.

Dated: January 9, 2018.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.